CSL (ASX:CSL) Other Current Payables : A$0 Mil (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is CSL Other Current Payables?

CSL's Other Current Payables for the quarter that ended in Dec. 2023 was A$0 Mil.

CSL's quarterly Other Current Payables increased from Dec. 2022 (A$0 Mil) to Jun. 2023 (A$3,169 Mil) but then declined from Jun. 2023 (A$3,169 Mil) to Dec. 2023 (A$0 Mil).

CSL's annual Other Current Payables increased from Jun. 2021 (A$1,984 Mil) to Jun. 2022 (A$2,432 Mil) and increased from Jun. 2022 (A$2,432 Mil) to Jun. 2023 (A$3,169 Mil).

CSL Other Current Payables Historical Data

The historical data trend for CSL's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSL Other Current Payables Chart

CSL Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Current Payables

Get a 7-Day Free Trial

1,418.54

1,546.23

1,983.84

2,432.48

3,169.23

CSL Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Payables	Get a 7-Day Free Trial															-	2,432.48	-	3,169.23	-

CSL Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

CSL Other Current Payables Related Terms

Thank you for viewing the detailed overview of CSL's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

CSL (ASX:CSL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (ASX:CSL) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

CSLLY:USA CMXHF:USA CSJ:Germany

Address

655 Elizabeth Street, Melbourne, VIC, AUS, 3000

Website

https://www.csl.com

CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include non-plasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.